CCM Investment Advisers LLC lifted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 72,801 shares of the company’s stock after buying an additional 2,054 shares during the period. CCM Investment Advisers LLC’s holdings in Procter & Gamble were worth $12,205,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of PG. Acorn Creek Capital LLC grew its holdings in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. grew its holdings in Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after buying an additional 59 shares in the last quarter. Traveka Wealth LLC lifted its stake in Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC grew its stake in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after acquiring an additional 61 shares in the last quarter. Finally, Valued Wealth Advisors LLC lifted its position in shares of Procter & Gamble by 11.2% during the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after purchasing an additional 61 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Down 1.9 %
Shares of PG traded down $3.04 during mid-day trading on Friday, reaching $159.06. The company’s stock had a trading volume of 2,814,364 shares, compared to its average volume of 5,918,190. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market cap of $374.59 billion, a PE ratio of 27.42, a P/E/G ratio of 3.70 and a beta of 0.45. The company’s fifty day moving average price is $169.77 and its two-hundred day moving average price is $169.64. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 75,439 shares of company stock worth $13,317,460 over the last 90 days. 0.18% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on PG. JPMorgan Chase & Co. boosted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. DA Davidson restated a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a research note on Friday, December 27th. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Finally, Piper Sandler initiated coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $179.75.
View Our Latest Stock Analysis on PG
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Health Care Stocks Explained: Why You Might Want to Invest
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Short a Stock in 5 Easy Steps
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Investing in the High PE Growth Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.